FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely oncology, and may be used for preventing malignant diseases. To this effect, the chemopreparations are used within the metronomic therapeutic regimen, while bacterial vaccines or viruses are used as an adjuvant.
EFFECT: using the given method enables higher specific immune response to the tumours and additionally stimulates the non-specific immunity and improves the cytolytic activity of the therapy.
10 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING ONCOLOGICAL DISEASES | 2008 |
|
RU2379055C1 |
METHOD FOR TREATMENT OF ONCOLOGY DISEASES | 2004 |
|
RU2271831C1 |
METHOD OF TREATING METASTATIC CANCER USING SENDAI VIRUS | 2017 |
|
RU2662916C1 |
LASER VACCINATION METHOD FOR PATIENTS SUFFERING FROM METASTATIC CANCER TYPE | 2005 |
|
RU2345788C2 |
METHOD FOR PRODUCING LIVE CELL VACCINE FOR BREAST CANCER PREVENTION | 2008 |
|
RU2407789C2 |
COMBINATION CELL IMMUNOTHERAPY OF MALIGNANT TUMORS | 2020 |
|
RU2787623C2 |
METHOD FOR PREDICTING AND TREATING MASTOPATHY | 2004 |
|
RU2280407C2 |
TESTICULAR VACCINE AS AN ANTITUMOUR PROPHYLACTIC AGENT | 2021 |
|
RU2784803C1 |
METHOD FOR STIMULATING PRESENTING ACTIVITY OF DENDRITIC CELLS | 2019 |
|
RU2728592C1 |
COMBINED CELL TRANSPLANT BASED ON LYMPHOKINE-ACTIVATED KILLERS AND DENDRITE CELLS, METHOD FOR PRODUCTION THEREOF AND METHOD FOR TREATMENT AND PROPHYLAXIS OF MALIGNANT, INFECTIVE DISEASES AND IMMUNODEFICIENT CONDITIONS | 2006 |
|
RU2309753C1 |
Authors
Dates
2013-12-10—Published
2011-11-16—Filed